Suzhou, China

Qing Shao


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qing Shao - Innovator in Antiviral Drug Development

Introduction

Qing Shao is a notable inventor based in Suzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral drugs. His innovative work focuses on creating effective treatments for viral infections, including influenza.

Latest Patents

Qing Shao holds a patent for a pyridone derivative, which is a composition and use as an antiviral drug. This patent describes a novel pyridone derivative represented by Formula (I) or its stereoisomers, pharmaceutically acceptable salts, solvates, or crystals. The invention is aimed at preventing or treating diseases such as influenza type A and B viral infections. The compounds demonstrated significant activity in inhibiting influenza endonuclease and influenza DNA, showcasing their potential in clinical applications.

Career Highlights

Qing Shao is associated with Jiangxi Caishi Pharmaceutical Technology Co., Ltd., where he continues to advance his research in antiviral drug development. His work has the potential to significantly shorten the duration of influenza infections and reduce mortality rates associated with these viral diseases.

Collaborations

Qing Shao collaborates with talented colleagues, including Li Chen and Xiaojian Xue, who contribute to his research efforts. Their combined expertise enhances the innovative potential of their projects.

Conclusion

Qing Shao's contributions to antiviral drug development highlight his role as a key innovator in the field of medicinal chemistry. His work promises to improve treatment options for viral infections, making a significant impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…